Skip to main navigation
Careers
Contact Us
About Us
Corporate Governance
Executive Leadership
Board of Directors
Sustainability
Ethics & Integrity
News & Events
Press Releases
Events & Presentations
Investors
Investor Kit
Stock Information
Financials
SEC Filings
Therapeutic Areas
Cardiopulmonary
Difficult-to-Treat Depression
Drug-Resistant Epilepsy
Search
LivaNova Reports First Quarter 2018 Results
Display Title
LivaNova Reports First Quarter 2018 Results
Weight
5
Group
2018